The expression of CCKBR was also identified in gastroenteropancreatic tumors, leiomyomas and leiomyosarcomas [11] indicating wide application prospects of the radiolabeled minigastrin analogues for diagnosis and therapy of the CCKBR-positive cancers. This evidence concerns the gene CCKBR and leiomyosarcoma.